Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $7.2500 (-1.49%) ($6.9800 - $7.4200) on Fri. Jun. 21, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.44% (three month average) | RSI | 66 | Latest Price | $7.2500(-1.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.1% a day on average for past five trading days. | Weekly Trend | TGTX advances 3.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(65%) ARKG(58%) IBB(58%) ARKK(57%) IWO(57%) | Factors Impacting TGTX price | TGTX will decline at least -1.72% in a week (0% probabilities). VXX(-38%) TLT(-9%) UUP(-6%) IFRA(-6%) IGOV(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.72% (StdDev 3.44%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
5 Day Moving Average | $7.5(-3.33%) | 10 Day Moving Average | $7.32(-0.96%) | 20 Day Moving Average | $7.1(2.11%) | To recent high | -14.5% | To recent low | 15.6% | Market Cap | $918m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |